Summary & Overview
CPT 88299: Unlisted Cytogenetic Procedure
CPT code 88299 designates an unlisted cytogenetic procedure for reporting cytogenetic services that lack a specific CPT code. This code is used nationally when laboratories perform nonstandard or novel cytogenetic analyses such as specialized karyotyping variations, advanced chromosome microarray techniques not otherwise specified, or other bespoke cytogenetic assays. Its use matters because unlisted codes require additional documentation and justification for medical necessity, affecting claims processing, reimbursement timelines, and prior authorization workflows.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find an overview of payer coverage considerations, typical billing and documentation expectations for unlisted cytogenetic reporting, and descriptions of where 88299 fits within cytogenetics service delivery. The publication summarizes common modifiers and administrative steps associated with unlisted procedure reporting, highlights clinical contexts that commonly generate unlisted cytogenetic claims, and outlines documentation elements payers typically request for adjudication.
This summary targets laboratory billing managers, medical coders, and compliance staff seeking a concise reference on 88299, including operational impacts on claims submission and the documentation needed to support medical necessity for atypical cytogenetic procedures. Data not available in the input.
Billing Code Overview
CPT code 88299 is an unlisted cytogenetic procedure code used to report cytogenetic services that do not have a specific CPT code. The code applies to laboratory procedures that analyze chromosomal structure and number when no precise code exists for the technique performed.
Service type: Laboratory — Cytogenetics
Typical site of service: Clinical laboratory or hospital laboratory
Clinical & Coding Specifications
Clinical Context
A typical patient is a 35–60 year-old referred for cytogenetic testing after abnormal findings on prenatal screening, hematologic workup, or tumor analysis. The clinician orders a cytogenetic assay that is not otherwise specified in the CPT code set, such as a novel fluorescence in situ hybridization (FISH) probe panel tailored to a rare chromosomal rearrangement, expanded karyotype with specialized culture conditions, or an uncommon molecular cytogenetic technique developed for research-use validation before commercialization. The workflow begins with specimen collection (peripheral blood, bone marrow, amniotic fluid, chorionic villus sampling, or surgical tumor tissue), proper labeling and transport to a cytogenetics laboratory, accessioning and test selection, specialized specimen processing and cell culture as required, execution of the unique cytogenetic assay, interpretation by a board-certified cytogeneticist or pathologist, and generation of a detailed report for the ordering provider. Billing uses 88299 when no specific CPT code exists for the exact cytogenetic procedure performed. Typical sites of service include hospital outpatient laboratories, independent reference laboratories, academic medical center cytogenetics labs, and specialized molecular diagnostic centers. Common clinical indications include unexplained congenital anomalies, recurrent pregnancy loss, unexplained infertility with suspected chromosomal causes, hematologic malignancies with atypical cytogenetic findings, and tumor profiling when non‑standard cytogenetic tests are required.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|